2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Meletios A. Dimopoulos: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients Lenalidomide, Adriamycin, Dexamethasone - Multiple Myeloma | Phase 2 | Completed | Meletios A. Dimopoulos | 45 | 2014-11-01 | 2016-10-17 |
| Bortezomib, Dexamethasone, and Rituximab in Previously Untreated Patients With Waldenstrom's Macroglobulinemia Bortezomib, Rituximab, Dexamethasone - Waldenstrom's Macroglobulinemia | Phase 2 | Completed | Meletios A. Dimopoulos | 59 | 2007-03-01 | 2021-04-30 |
Lymphoma (1) · Multiple Myeloma (1) · Waldenstrom Macroglobulinemia (1)
Dexamethasone (2) · Bortezomib (1) · Doxorubicin (1) · Lenalidomide (1) · Rituximab (1)
Greece (2) · Netherlands (1) · Spain (1)
Argirios Symeonidis, Doctor (1) · Eirini Katodritou, Doctor (1) · Meletios A Dimopoulos, MD (1) · Meletios Dimopoulos, Doctor (1) · Nikolaos Anagnostopoulos, Doctor (1)